Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Cancer. 2011 May 19;117(23):5359–5369. doi: 10.1002/cncr.26195

Figure 2. Protein biomarker expression in human PLS.

Figure 2

A. “Heatmap” summarizing expression levels of each of the proteins evaluated in all individual scorable samples (* VEGF was only scored as positive or negative); B. Immunohistochemical images demonstrating representative levels of evaluated markers in human PLS specimens (controls included as insets: PPARγ = low expressing PLS, adipophilin = DDLPS, BCL2 = low expressing PLS, survivin = low expressing UPS/MFH, p16 = low expressing PLS, Rb = high expressing PLS, CDK4 = DDLPS, VEGF = negative expression PLS, MMP2&9 = negative expressing PLSs, EGFR = low expressing PLS, MDM2 = DDLPS, p53 = low expressing PLS). All original images were captured at ×200 magnification.